2minutemedicine.com20h
5-Aminosalicylic Acid may not be an effective combination with ustekinumab for inflammatory bowel disease
Overall, the use of 5-aminosalicylic acid (5-ASA) in combination with ustekinumab (UST) did not provide a significant benefit in patients with inflammatory bowel disease (IBD). Evidence Rating Level: ...
2minutemedicine.com1d
Couple-based intervention may be more effective in the management of type 2 diabetes in adults
A couple-based intervention strategy for Chinese adults with type 2 diabetes mellitus (T2DM) showed greater decreases in HbA1c in patients with a high baseline HbA1c compared to an individual-based ...
2minutemedicine.com1d
Intra-arterial tenecteplase has limited use after successful endovascular recanalisation of acute posterior circulation arterial occlusion
In patients with acute ischemic stroke due to acute intracranial occlusions of the posterior circulation, the use of ...
2minutemedicine.com1d
Semaglutide may aid tobacco cessation in patients with comorbid diabetes
In this retrospective study of patients with comorbid type 2 diabetes mellitus and tobacco use disorder (TUD), semaglutide ...
2minutemedicine.com3d
The Scan by 2 Minute Medicine®: Another Viral Virus, Is One Drink Too Much?, Eggs, Humans, and the Flu, and Detrimental Exercise:
Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We begin with a ...
2minutemedicine.com3d
Genome classifiers may aid prostate cancer risk stratification and treatment
In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...
2minutemedicine.com4d
Verona’s Ohtuvayre shows promise in the treatment and management of Chronic Obstructive Pulmonary Disease
Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...
2minutemedicine.com4d
Thymosin α1 administration not associated with improved mortality in septic patients
1. The use of thymosin α1 in adult patients with sepsis was not associated with a reduction in all cause 28 day mortality. Evidence Rating Level: 1 (Excellent) Thymosin α1 is an immodulatory therapy ...